How to Model for Loss of Exclusivity and Generic Entrants
29th March 2023Whether a direct threat to your originator brand, or a competitor brand losing patent, either way, it is important to build the impact into your forecast structure.
Taking the right forecasting approach for rare diseases
8th December 2022Generating accurate forecasts for rare diseases can be challenging, especially when the treatable population is in the hundreds and there is little data to get you from one number to the next.
Accelerate Your Forecasting Process with J+D’s Proprietary Software Tool: A Case Study
7th April 2022J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
What makes a good (and bad) pharmaceutical forecast model
9th November 2022Forecasting is essential in providing clarity on decision making about the future, and good quality forecasts can prevent decisions being made which could be commercially damaging to organisations.
Tips for Forecasting First in Class Treatments
9th November 2022The first step to creating a forecast for a first-in-class treatment is to define your model structure based on the potential source of business.
J+D release FC365 Lite
20th March 2023For pharma clients looking to take their first steps into an integrated forecasting solution.
‘What if’ there was a way to make scenario analysis quick and easy
14th November 2022Carrying out ‘what-if’ analysis is a way for key stakeholders in forecasting to immediately explore the impact of changing key assumptions and ultimately make better decisions. FC365 makes this easy.
Master patient flow analysis to predict pharma demand and provide better patient access.
16th June 2022Key considerations for creating more accurate patient-based product forecasts.
Expert strategies to overcome the inherent inaccuracy of long range pharma forecasting
27th May 2022Here we discuss why managing risk & opportunity is more important than accuracy when tackling your long range planning (LRP)
J+D develop ‘Goal Seeker’ tool for enhanced pharmaceutical forecasting
25th November 2022Announcing the development of a forecasting tool to bring the analyst’s tool kit to the next level.
FC+ Continues to go from strength to strength
3rd November 2022Innovating our suite of forecasting software for independent pharmaceutical forecasting.
How people rate our pharma forecasting training
24th August 2022Our fresh and friendly approach to pharma forecasting training translates into improved confidence in forecasting and clarity in implementation, but don't just take our word for it, read what people say about our training courses.